After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has shown remarkable potential in...
Developed at UdeM, the molecule could soon be approved in Europe to treat blood cancers in patients without a compatible donor – a major step towards...